DOCSLIB.ORG

Download EAU Programme

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Table of Contents Welcome by the EAU Secretary General 2 Welcome by the EAU Congress President 3 EAU patrons and contributors 4 Synopsis 6 General Floorplans congress venue 17 General information 20 Speakers’ guidelines 24 Social programme 25 Excursions 26 About Paris 28 Congress hotel listing 31 Programme Wednesday, 5 April 35 Programme Thursday, 6 April 89 Programme Friday, 7 April 175 Programme Saturday, 8 April 263 ESU Courses and Hands-on training sessions ESU courses 271 ESU/ESUT hands-on laparoscopy courses 308 Hands-on training sessions 312 EAU Section meetings 315 European Society of Residents in Urology (ESRU) Programme 335 European Assocation of Urology Nurses (EAUN) Programme 337 About EAU of Contents Table EAU Membership 343 EAU Offices 344 European Urology Accredited Medical Education Programme 346 Continuing Medical Education - Accreditation points national urological associations 347 Historical overview EAU Congresses 348 Indexes DVD library 350 List of abstract authors and presenters 380 List of abstracts sorted by topic 408 List of sessions sorted by topic 411 List of speakers (not abstracts) 412 1 Welcome to Paris Dear Colleagues, Bienvenue à Paris! It is a tremendous honour and pleasure to welcome you to my home city for the 21st Annual EAU Congress from 5-8 April 2006. It is 10 years since the EAU Congress was held in Paris and in that interim period the EAU has grown into a multi-faceted professionally renowned organisation. The 21st Annual EAU Congress will provide a platform for you to interact with your colleagues, will stimulate and create an exchange of ideas and will be personally rewarding. As professionals in the field of urology we are constantly striving to increase our Prof. Pierre Teillac knowledge and with this in mind the EAU Scientific Committee have compiled an EAU Secretary General exciting and varied programme. The high-quality scientific programme will open new perspectives on issues related to treatment and patient care. The plenary sessions and core symposia will indeed provide you with a full update on the most important aspects and latest achievements in urology. The Congress will also serve the educational mission of the EAU through a variety of courses and hands-on training sessions organised by the European School of Urology (ESU). The Congress will be fully accredited by the EU-ACME (European Urology - Accredited Continuing Medical Education). To coincide with the scientific programme, an extensive commercial exhibition will be held where companies and suppliers will exhibit their newest innovations. Your participation in this Congress will also be an opportunity for you to discover, or rediscover, Paris – City of Light. Paris is a city of art and theatre, of The Eiffel Tower and Notre Dame, of the Champs Elysées and the Canal St-Martin, of nightclubs and the Moulin Rouge - never a dull moment in this historic, romantic and bustling city. I look forward to welcoming old friends and meeting new ones in what promises to be a successful and memorable Congress! 2 Dear colleagues, It is a great pleasure for me to welcome you to Paris for the 21st Annual EAU Congress. The Annual EAU Congress is one of the most important events of our association and it is only with the dedication of many people that a medical congress of this magnitude and diversity can be realised. This programme book is the result of the commitment of the EAU Scientific Office together with all those people who have directly contributed or who are taking part in the programme. The aims of the programme are twofold: Prof. Laurent Boccon-Gibod Firstly, the plenary and sub-plenary sessions will deliver up-to-date scientific President 21st Annual EAU Congress information to delegates engaged in clinical practice, providing a full update on the latest developments in the field of urology which clearly indicates what can be achieved or utilised and what remains debatable. Secondly, the abstract sessions are a platform to foster scientific exchanges and discussions between clinician-researchers, based on recently concluded work or work in progress. The plenary and sub-plenary programme is the culmination of the hard work of the EAU Scientific Office under the guidance of Professor F. Hamdy. Leafing through the programme book, you will find that ‘no (urological) stone has been left unturned’ and that the majority of the questions of the day will be addressed, if not answered. One of the measures of a successful congress is through its scientific submissions and these are the direct result of your personal energetic input. The Paris Congress sets a new record for abstract submissions with more than 3.200 abstracts being submitted. You can be assured that reviewers and members of the EAU Scientific Office have done their best to compile a marvelous programme, the only regret being that they were unable to accept more papers due to time and space constraints. I wish you an excellent 2006 EAU Congress in Paris. Welcome to Paris Welcome 3 EAU Patrons and Contributors The European Association of Urology respectfully acknowledges the EAU Corporate Sponsors and all other sponsors for providing educational grants and services to the 21st Annual EAU Congress EAU Platinum Corporate sponsors ASTELLAS BOEHRINGER INGELHEIM GMBH/ELI LILLY & COMPANY GLAXOSMITHKLINE LILLY ICOS LLC MSD NOVARTIS PHARMA AG/NOVARTIS ONCOLOGY PFIZER INC PIERRE FABRE MÉDICAMENT SANOFI-AVENTIS EAU Gold Corporate sponsors BAYER HEALTHCARE AG BOEHRINGER INGELHEIM GMBH IPSEN KARL STORZ GMBH & CO.KG SANOFI PASTEUR Congress Contributors ABBOTT MOLECULAR ASTRAZENECA BOSTON SCIENTIFIC EDAP GEN-PROBE INCORPORATED LUMENIS GMBH STEBA BIOTECH/NEGMA UCB PHARMA 4 5 Wednesday, 5 April Level 1 Level 2 Level 3 eURO Room Room Room Room Room Room Room Auditorium Ternes Blue Maillot 242 251 252 Bordeaux 08.00 08.30-12.30 08.30-12.30 08.30-12.30 08.30-12.30 08.30-12.30 08.30-13.45 EAU Section EAU Section EAU Section EAU Section EAU Section EAU Section meeting meeting meeting meeting meeting meeting 09.00 ESOU ESFU ESGURS ESNU ESUI ESUT Uro-oncological Update on Reconstructive Introducing the Innovative What’s new in 10.00 surgery: Tricks female urology surgery of the second European imaging in and uro-technology? and techniques pelvis masterclass on around urology Botulinum EORTC toxin for the 11.00 GU-group overactive bladder From clinical trials to patient care 12.00 page 316 page 315 page 322 page 328 page 330 12.45-14.15 12.45-14.15 12.45-14.15 12.45-14.15 12.45-14.15 12.45-14.15 12.45-14.15 13.00 Video Poster Oral Poster Poster Poster Poster Session 1 Session 1 Session 1 Session 2 Session 3 Session 4 Session 5 Surgical anatomy Sexual function Urothelial Kidney tumours: Research and drug Urothelial Basic research in laparoscopic and dysfunction: tumours: Basic research therapy for stone tumours: Basic developments in page 334 radical Basic research Management of disease research I female urology prostatectomy infiltrative/ 14.00 advanced tumours I V1-V6 9-23 1-8 24-38 39-53 54-68 69-83 page 38 page 40 page 39 page 42 page 44 page 46 page 48 14.30-16.00 14.30-16.00 14.30-16.00 14.30-16.00 14.30-16.00 14.30-16.00 14.30-16.00 14.30-16.00 15.00 Video Poster Oral Poster Poster Poster Poster Oral Session 2 Session 10 Session 2 Session 11 Session 12 Session 13 Session 14 Session 3 Advances in Ejaculatory Urological Kidney tumours: Update on Urothelial Non-neurogenic Prostate cancer laparoscopic pelvic dysfunction: Basic reconstruction I Diagnosis and ureteroscopy and tumours: Basic voiding stem cells surgery and clinical staging I stents research II dysfunction: The research bladder factor V7-V12 161-175 145-151 176-190 191-205 206-220 221-235 153-160 page 58 page 62 page 59 page 64 page 66 page 68 page 70 page 61 16.00 16.15-17.45 16.15-17.45 16.15-17.45 16.15-17.45 16.15-17.45 Symposium Symposium Symposium Symposium Symposium Managing the Helping couples Advancing the Vascular-targeted Prostate cancer LUTS/BPH patient: stay connected - management of photodynamic prevention: The impact of new paradigms in OAB: New data, therapy with A relevant nocturia ED management new directions Tookad (VTP) for therapeutic the treatment of target for patients localised prostate with BPH 17.00 cancer ASTELLAS/ BOEHRINGER BAYER STEBA BIOTECH/ INGELHEIM HEALTHCARE AG PFIZER INC NEGMA MSD page 80 page 81 page 82 page 85 page 83 18.00 18.15-21.00 19.00 Opening Ceremony & 20.00 Welcome Cocktail page 88 21.00 6 Wednesday, 5 April Level 3 Level 4 Room Room Room Room Room Room Room Room Room Room Havana 341 342 343 351 353 352 Concorde 1 Concorde 2 Concorde 3 08.30-12.30 08.30-12.30 08.30-12.30 08.30-12.30 08.30-12.30 08.30-12.00 08.30-12.30 08.00 EAU Section EAU Section EAU Section EAU Section EAU Section EAU/CAU EAU Section meeting meeting meeting meeting meeting joint Session meeting 09.00 ESIU ESUP ESTU ESUR ESAU 09.30-11.00 eULIS Difficult Morphological Controversies ‘...omics in What’s new in ISSAM Session Difficult cases infections in changes in in immuno- urological andrology? An of urolithiasis: 10.00 urology prostate tissue suppression disease’ old head on Testosterone Medical and following the and hot topics young and male surgical various forms in renal shoulders aging in solutions of treatment transplan- urological 11.00 tation practice page 37 page 35 page 324 page 333 page 320 page 332 page 318 page 326 12.00 12.30-18.00 12.45-14.15 12.45-14.15 12.45-14.15 12.45-14.15 13th ESRU 13.00 Poster Meeting Poster Poster Poster Session 6 Session 7 Session 8 Session 9 Urethral Prostate Laparoscopic
Recommended publications
  • University of California, San Diego

    University of California, San Diego

    UNIVERSITY OF CALIFORNIA, SAN DIEGO The post-terminal differentiation fate of RNAs revealed by next-generation sequencing A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Biomedical Sciences by Gloria Kuo Lefkowitz Committee in Charge: Professor Benjamin D. Yu, Chair Professor Richard Gallo Professor Bruce A. Hamilton Professor Miles F. Wilkinson Professor Eugene Yeo 2012 Copyright Gloria Kuo Lefkowitz, 2012 All rights reserved. The Dissertation of Gloria Kuo Lefkowitz is approved, and it is acceptable in quality and form for publication on microfilm and electronically: __________________________________________________________________ __________________________________________________________________ __________________________________________________________________ __________________________________________________________________ __________________________________________________________________ Chair University of California, San Diego 2012 iii DEDICATION Ma and Ba, for your early indulgence and support. Matt and James, for choosing more practical callings. Roy, my love, for patiently sharing the ups and downs of this journey. iv EPIGRAPH It is foolish to tear one's hair in grief, as though sorrow would be made less by baldness. ~Cicero v TABLE OF CONTENTS Signature Page .............................................................................................................. iii Dedication ....................................................................................................................
  • Administration of Aromatase Inhibitor MPV-2213Ad to Blue Fox Vixens (Vulpes Lagopus) As a Model for Contraception in Female Dogs*

    Administration of Aromatase Inhibitor MPV-2213Ad to Blue Fox Vixens (Vulpes Lagopus) As a Model for Contraception in Female Dogs*

    Theriogenology 152 (2020) 53e63 Contents lists available at ScienceDirect Theriogenology journal homepage: www.theriojournal.com Administration of aromatase inhibitor MPV-2213ad to blue fox vixens (Vulpes lagopus) as a model for contraception in female dogs* * L. Lindh a, 1, , H. Lindeberg b, 1, A. Banting c, S. Banting c, S. Sainmaa d, S. Beasley e, H.T. Korhonen f, O.A.T. Peltoniemi a a University of Helsinki, Department of Production Animal Medicine, FIN-04920, Saarentaus, Finland b Natural Resources Institute Finland (LUKE), Production Systems, Halolantie 31 A, FIN-71750, Maaninka, Finland c La Bergerie, 37230, ST Etienne de Chigny, France d Korkeasaari Zoo, Mustikkamaanpolku 12, FIN-00570, Helsinki, Finland e Vetcare Oy, Liedontie 45, FIN-04600 Mants€ al€ a,€ Finland f Natural Resources Institute Finland (LUKE), Production Systems, Teknologiakatu 7, FIN-67100 Kokkola, Finland article info abstract Article history: The interest in non-surgical approaches to contraception and fertility control in female dogs has Received 31 May 2019 increased in recent years. In this study the effect of an aromatase inhibitor (finrozole) was evaluated in Received in revised form fur production animals, farmed blue fox vixens, as a model for contraception in bitches. A total of 80 7 April 2020 vixens were divided into 4 groups, receiving orally placebo (A) or finrozole 0.5 mg/kg (B), 3.5 mg/kg (C) Accepted 8 April 2020 or 24.5 mg/kg (D) for 21 consecutive days beginning in the pre-ovulatory period of heat. Monitoring of Available online 15 April 2020 the vixens included clinical signs of heat, measurement of vaginal electrical resistance (VER) as well as oestradiol and progesterone concentrations in plasma.
  • (12) United States Patent (10) Patent No.: US 8,309.603 B2 Dalton Et Al

    (12) United States Patent (10) Patent No.: US 8,309.603 B2 Dalton Et Al

    USOO8309.603B2 (12) United States Patent (10) Patent No.: US 8,309.603 B2 Dalton et al. (45) Date of Patent: Nov. 13, 2012 (54) SARMS AND METHOD OF USE THEREOF 4,191,775 A 3, 1980 Glen 4,239,776 A 12/1980 Glen et al. (75) Inventors: N SR n, t TN (S), 4,386,0804,282,218 A 5/19838, 1981 CrossleyGlen et al. et al. uane D. Miller, Germantown, 4411,890 A 10/1983 Momany et al. (US); Jeff Kearbey, Lakeland, TN (US) 4,465,507 A 8/1984 Konno et al. 4,636,505 A 1/1987 Tucker (73) Assignee: University of Tennessee Research 4,880,839 A 1 1/1989 Tucker Foundation, Knoxville, TN (US) 5,162,504 A 11/1992 Horoszewicz s s 5,179,080 A 1/1993 Rothkopfet al. (*) Notice: Subject to any disclaimer, the term of this ises: A 32. Swissan et al. patent is extended or adjusted under 35 5,656,651 A 8, 1997 Sovak et al. U.S.C. 154(b) by 212 days. 6,019,957. A 2/2000 Miller et al. 6,043,265 A 3/2000 Murugesan et al. 6,071,957 A 6/2000 Miller et al. (21) Appl. No.: 12/730,094 6, 160,011 A 12/2000 Miller et al. 6,482,861 B2 11/2002 Miller et al. (22) Filed: Mar. 23, 2010 6,492,554 B2 12/2002 Dalton et al. 6,548,529 B1 4/2003 Roblet al. (65) Prior Publication Data 6,569,896 B2 5/2003 Dalton et al.
  • A Historical Perspective on Condoms

    A Historical Perspective on Condoms

    Reprinted from: Condoms in the Prdventibn of Sexually Transmitted 89-56 Diseases: proceedings of a conference, Atlanta, Georgia February 1987 (Research Triangle Park, NC: American Social Health Association, 1989) pp. 1-3 A Historical Perspective On Condoms Paul J.Feldblum, 1 M.S.P.H. protector Minos. She slipped the sheath is "armor against 2 love, Michael J.Rosenbei g,M.D., M.P.H. bladder of a goat into the vagina of a gossamer against infection."2 woman. Into this bladder Minos Until this time, the word condom 'Reproductive Epidemiology cast off his serpent-bearing semen. had not yet been coined; we may Division Then he went to find Pasiphae and never know its origin. An Family Health International cohabited with her. apocryphal story has it that the Research Triangle Park, NC 27709 Clearly, disease prophylaxis was word condom derives from Dr. paramount in this early user's mind. Condom, a court physician to King Departments of Epidemiology and Using this novel Obstetrics-Gynecology technique, Charles II,who reigned from 1660 to Pasiphae had eight children. Some 1685. The king became alarmed at University of North Carolina classicists believe that this rather his wealth of illegitimate children Chapel Hill, NC 27599 nasty legend exhibits misciassifica- and the good doctor helped him tion in that it was actually Minos prevent further errors, for which the and not his female partner who relieved king knighted this planned wore the goat The Ancients bladder sheath. At parenthood pioneer.' We know that any rate, this is the only reference to the term first appeared in print in a Evidence for condom use by the a male barrier device in either the 1717 English work on syphilis as ancients is sparse and ambiguous, ancient Greek or Roman sources.
  • Lycée Louis Thuillier (Amiens) Lycée Robert De Luzarches (Amiens)

    Lycée Louis Thuillier (Amiens) Lycée Robert De Luzarches (Amiens)

    Report on website usage and related activities Website : http://www.jewsofthesomme.com David Rosenberg and Lydia Rosenberg Pittsburgh, Pennsylvania U.S.A., May 2021 I. Website Usage (provided by Squarespace Analytics) : From 20 Juin 2020 to 12 Mai 2021 Visits/visites : 3.6 K Unique visitors: 2.2 K Page views : 8.3 K Visits by country : USA 2,166 60.1 % France 1,077 29.9 % Other countries 10 % France – 1.077 Localisation par département (visites) : Somme 428 (dont Amiens 332) Paris 164 Oise 60 Nord 38 Hautes de Seine 34 Territoire de Belfort 27 Eure 24 Rhône 20 Pas de Calais 17 Aisne 17 Yvelines 17 Val d’Oise 14 Seine-Saint-Denis 14 Seine-et-Marne 11 Val-de-Marne 9 Ile-et-Villaine 7 Alpes-Maritime 7 Charente- Maritime, Calvados, Puy-de-Dome, Meurthe-et-Moselle, Loire Atlantique, Bouches-de-Rhone 6 chacun Seine-Maritime, Haute-Marne, Gironde 5 chacun Herault, Haute Garonne 4 chacun Isere, Var, Meuse, Vaucluse 3 chacun Vendee, Manche, Finistere, Inre-et-Loire, Essonne, Ardennes, Morelle, Gard, Tarn 2 chacun Une seule visite : Morbihan, Marne, Cotes-d’Amor, Eure-et-Loire, Cher, Indre, Deux-Sevres, Vienne, Charente, Aube, Bas-Rhin, Nievre, Drome, Ain, Haute-Savoie, Hautes-Alpes, Landes, Lot-et-Garonne U.S. Visits : Total 2,166 (detail of states in Appendix) II. Prêt de l’Exposition « Etre Juif dans la Somme » Trois lycées publics à Amiens ont utilisé l’exposition “Etre Juif dans la Somme, 1940-1945” dont les panneaux sont à la Bibliothèque universitaire/Citadelle, UPJV Lycée Madeleine Michelis (Amiens) Lycée Louis Thuillier (Amiens) Lycée Robert de Luzarches (Amiens) Deux autres établissements scolaires viennent de se servir de cette même exposition : Collège Millevoye d’Abbeville, du 6 au 16 avril 2021 Collège Béranger de Péronne, du 17 au 25 mai 2021 French exhibit panels borrowed by three lycées in Amiens and two collèges/middle schools, one in Abbeville, the other in Péronne) III.
  • Pass Cultur E

    Pass Cultur E

    Forum des sports Extraits de PA S S C U L T URE l’agenda du Maire 11 SEPTEMBRE Place du Marché Forum des sports À l’affiche ce mois-ci 3 Juin : vernissage à la galerie d’art contemporain Adodart ; Journées du patrimoine Réception en l’honneur de Maurice Herzog – 5 juin : journées 11 SEPTEMBRE Place du Marché Pierre Richard Kiki Van Beethoven d’entraide de l’Église Réformée ; 30 ans de l’ASGN – 6 juin : Franchise postale Comédie au Théâtre fête du club de rugby (RCPN) en présence du club anglais – 18 et 19 SEPTEMBRE Théâtre la Pépinière. La Bruyère. 7 juin : rencontre avec les dirigeants du centre ALEF ; dîner 2010 Septembre de l’Amicale des médecins – 8 juin : accueil des journées des Journées du patrimoine À partir du Tarifs premières CATTP (Centre d’accueil pour handicapés) du 92 ; remise du 28 septembre catégorie représentations du Course pédestre € € n° 18 Trophée du Golf – 10 juin : visite du square Prévert ; soirée 18 et 19 SEPTEMBRE 1 à 18 au lieu de 34 21 au 30 septembre du personnel de la mairie – 11 juin : déjeuner avec le direc- 3 OCTOBRE Parvis de l’Hôtel de Ville Catégorie unique Bonne rentrée à tous ! teur départemental de la Jeunesse et des Sports – 13 juin : Fréderic Diefenthal- 18 € au lieu de 33 € visite du quartier Windsor ; inauguration de l’immeuble de Gwendoline Hamon Cette nouvelle Lettre du Maire présente quelques-uns des projets d’aménagement logements sociaux rue Soyer ; fête de fin d’année à Saint Course pédestre Kramer contre Kramer Dominique ; fête du Judo ; concours de poésie lusophone Rencontres bénévoles et associations aux Bouges Parisiens.
  • LISTE DES ETABLISSEMENTS RECEVANT DU PUBLIC Commune

    LISTE DES ETABLISSEMENTS RECEVANT DU PUBLIC Commune

    PREFECTURE DES HAUTS-DE-SEINE LISTE DES ETABLISSEMENTS RECEVANT DU PUBLIC Commune : ANTONY 1ère catégorie COMPLEXE SPORTIF"LIONNEL TERRAY" rue de l'Annapurna X INSTITUTION SAINTE MARIE 2, rue de l'Abbaye RI LYCEE DESCARTES 1, avenue Lavoisier R MARCHE COUVERT rue du Marché M MONOPRIX 16/24, rue Auguste Mounié M PARC DEPARTEMENTAL DES SPORTS 148 bis, avenue du Général de Gaulle PA PARKING DES BACONNETS place des Baconnets PS RESIDENCE UNIVERSITAIRE JEAN ZAY 55, avenue du Général de Gaulle R 2ème catégorie CENTRE ANDRE MALRAUX 1, avenue Léon Harmel L CENTRE SPORTIF LIONEL TERRAY 164 bis, avenue du Président Kennedy R COLLEGE ANNE FRANCK 110/112, rue Adolphe Pajeaud R COLLEGE DESCARTES 19, avenue Lavoisier R CONSERVATOIRE DARIUS MILHAUD 136/140, avenue de la Division Leclerc R EGLISE SAINT JEAN PORTE LATINE rue Fontaine Mouton V GROUPE SCOLAIRE FERDINAND BUISSON 1/3, rue Auguste Mounier R GROUPE SCOLAIRE PAUL BERT 67, avenue Jean Monnet R HOPITAL PRIVE D'ANTONY 25, avenue de la Providence U INSTITUT UNIVERSITAIRE DE FORMATION 26, avenue Léon Jouhaux R INSTITUTION SAINTE MARIE DE LA CROIX 21 bis, rue Auguste Mounié R MAGASIN SIMPLY MARKET (EX ATAC) 134, rue Pascal M PARC DE STATIONNEMENT Place Firmin Génier PS PARC DE STATIONNEMENT rue du Marche PS PAROISSE SAINT-SATURNIN D'ANTONY 2, place de l'Eglise V PRIMAIRE LES RABATS 167/173, rue des Rabats R 3ème catégorie BATIMENT CENTRAL 148 bis, av du Général de Gaulle X BIBLIOTHEQUE MUNICIPALE 20, rue Maurice Labrousse L CENTRE DE FORMATION 101, rue de la Fontaine Grelot R CENTRE HOSPITALIER SPECIALISE
  • Suomalaisyritykset Ranskassa – Entreprises Finlandaises En France Päivitetty/Mise À Jour: Heinäkuu/Juillet 2018

    Suomalaisyritykset Ranskassa – Entreprises Finlandaises En France Päivitetty/Mise À Jour: Heinäkuu/Juillet 2018

    Suomalaisyritykset Ranskassa – Entreprises finlandaises en France Päivitetty/Mise à jour: heinäkuu/juillet 2018 ABLOY France AHLSTROM Research and Services 533 avenue du Général de Gaulle Zone industrielle de l'Abbaye, 364 Impasse FR-92140 CLAMART Louis Champin, CS 40002 http://www.abloy.fr/fr/abloy/abloyfr/ FR-38780 PONT-ÉVÊQUE http://www.ahlstrom.com AHLSTROM specialties SA ALLU France sarl 5 rue de la Papeterie 180 ZA les Bruottes FR-59166 BOUSBECQUE FR-21200 VIGNOLES http://www.ahlstrom.com http://www.allu.net ALMACO Group sas AMER SPORTS France sa 24 Rue de l'Europe 80 Rue Condorcet FR-44240 LA CHAPELLE SUR ERDRE FR-38096 VILLEFONTAINE http://www.almaco.cc http://www.amersports.com BASWARE sas CARGOTEC/HIAB 20 Rue Caumartin 38 Avenue Roger Hennequin FR-75009 PARIS FR-78190 TRAPPES http://www.basware.com/ http://www.hiab.com/fr-fr/monde CARGOTEC/KALMAR CENCORP AUTOMATION 265 Boulevard Jules Durand Joensuunkatu 7 C 76600 LE HAVRE FI-24100 SALO http://www.kalmar.fr/ http://cencorpautomation.com/ CHAMPION DOOR CIMRO Oy 8 rue de Moscou BP 34 Le Courné FR-75008 PARIS FR-31800 ASPRET-SARRAT www.championdoor.com www.ventilation-cimro.net CITEC ENGINEERING FRANCE s.a.r.l. CONFIDEX FRANCE 8 Rue Henri Becquerel Nice Premier – 6ème étage, 455 Promenade des FR-92500 RUEIL MALMAISON Anglais http://www.citec.fi/en- FR-06200 NICE US/Locations/Citec_France https://www.confidex.com/ CORENSO France TRÉFIMETAUX (CUPORI) P.O. Box 4 Kuparitie, P.O. Box 30 FR-33660 SAINT-SEURIN-SUR-L'ISLE FI-28101 PORI http://www.corenso.com www.trefimetaux.fr DOT.
  • Revised Draft Detailed Review Paper on Aromatase” Has Been Prepared for Dr

    Revised Draft Detailed Review Paper on Aromatase” Has Been Prepared for Dr

    This document “Revised Draft Detailed Review Paper on Aromatase” has been prepared for Dr. Gary E. Timm, Work Assignment Manager, U.S. Environmental Protection Agency, Endocrine Disruptor Screening Program, Washington, D.C. 20004, by BATTELLE, 505 King Avenue, Columbus, Ohio 43201, February 25 2002. EPA contract number 68-W-01-023, work assignment 2-7. 2 REVISED DRAFT DETAILED REVIEW PAPER ON AROMATASE EPA CONTRACT NUMBER 68-W-01-023 WORK ASSIGNMENT 2-7 February 25, 2002 PREPARED FOR GARY E. TIMM WORK ASSIGNMENT MANAGER U.S. ENVIRONMENTAL PROTECTION AGENCY ENDOCRINE DISRUPTOR SCREENING PROGRAM WASHINGTON, D.C. BATTELLE 505 KING AVENUE COLUMBUS, OH 43201 TABLE OF CONTENTS Page EXECUTIVE SUMMARY ................................................... 1 2.0 INTRODUCTION ................................................... 3 2.1 DEVELOPING AND IMPLEMENTING THE ENDOCRINE DISRUPTOR SCREENING PROGRAM (EDSP) ............................................ 3 2.2 THE VALIDATION PROCESS ..................................... 3 2.3 PURPOSE OF THE REVIEW ON THE AROMATASE ASSAY ................ 5 2.4 METHODOLOGY USED IN THE ANALYSIS ........................... 5 2.4.1 Literature Search ........................................ 5 2.4.2 Databases Searched ..................................... 5 2.4.3 Methods and Sources for Acquiring Additional Information ........... 6 2.5 DEFINITIONS (E.G., METHOD, PROCEDURE, TECHNIQUE, PROTOCOL) ....... 7 3.0 BACKGROUND ON AROMATASE ....................................... 9 3.1 ENDOCRINOLOGY OF ESTROGENS AND ROLE OF AROMATASE
  • Historia Del Condón Y Otros Métodos Anticonceptivos

    Historia Del Condón Y Otros Métodos Anticonceptivos

    Artículo Histórico Historia del condón y otros métodos anticonceptivos History of condoms and other contraceptive methods Est. Antonio Aguiar García1* Est. Laura Candelaria Almelo Hernández1 Est. Luis Alberto Lazo Herrera1 Dra. Grecia María Giniebra Marín1 Dra. Roxana Rivera Rivadulla1 1 Universidad de Ciencias Médicas de de Pinar del Río. de Pinar del Río, Cuba. *Autor para la correspondencia: [email protected] RESUMEN El uso del condón es un método eficaz para prevenir enfermedades venéreas y un embarazo no deseado. Años atrás se puede apreciar cómo se debate dónde y cómo los llamados dispositivos intrauterinos fueron utilizados por primera vez. La siguiente investigación se realizó con el objetivo de explicar el surgimiento y la evolución del condón y otros métodos anticonceptivos, para ello se utilizaron un total de 15 referencias bibliográficas. Es indudable que la anticoncepción tiene que figurar como elemento básico de la atención en medicina, el conocimiento de sus orígenes, historia y evolución es fundamental. Palabras clave: condones; sexualidad; historia. ABSTRACT The use of the condom is an effective method to prevent venereal diseases and an unwanted pregnancy. Years ago you can see how it is discussed where and how the 1 so-called intrauterine devices were used for the first time. The following investigation was carried out with the objective of explaining the emergence and evolution of the condom and other contraceptive methods, for which a total of 15 bibliographical references were used. Undoubtedly, contraception must figure as a basic element of medical care, knowledge of its origins, history and evolution is fundamental. Key words: condoms; sexuality; history.
  • Knowledge, Attitude and Practice of Condom Use Among out of School Adolescent Girls and Young Women Aged 15- 24: a Case Study of Majengo Slums, Nairobi County

    Knowledge, Attitude and Practice of Condom Use Among out of School Adolescent Girls and Young Women Aged 15- 24: a Case Study of Majengo Slums, Nairobi County

    UNIVERSITY OF NAIROBI DEPARTMENT OF SOCIOLOGY AND SOCIAL WORK KNOWLEDGE, ATTITUDE AND PRACTICE OF CONDOM USE AMONG OUT OF SCHOOL ADOLESCENT GIRLS AND YOUNG WOMEN AGED 15- 24: A CASE STUDY OF MAJENGO SLUMS, NAIROBI COUNTY BY WAMAITHA JOAN ESTHER C50/83184/2015 A RESEARCH PROJECT SUBMITTED IN PARTIAL FULFILMENT OF THE REQUIREMENT FOR THE AWARD OF THE DEGREE OF MASTER OF ARTS IN SOCIOLOGY (MEDICAL SOCIOLOGY), OF THEUNIVERSITY OF NAIROBI DECEMBER 2017 i DECLARATION I hereby declare that this research project is my original work and has not been presented for an award of a Degree to any other University. Signature ………………… Date………………………. Wamaitha Joan Esther C50/83184/2015 This research project has been submitted for examination with my approval as University supervisor. Signature………………. Date…………………………… Mr. Allan Korongo ii DEDICATION I dedicate this Research to my family my Mother Winfred Njogu and Sister Annjudy Wambui for their continuous support and prayers. iii ACKNOWLEDGEMENTS My heartfelt appreciation goes to the University Of Nairobi Department Of Sociology and Social Work and the Board of Post Graduate for awarding me a scholarship that made my study possible. I am grateful for this golden opportunity that was granted to me to advance my studies I stand forever thankful. I am sincerely grateful to my Supervisor Mr. Allan Korongo for his unwavering support, time, supervision and counsel he accorded to me in writing and conducting this Research. His professional guidance shaped my understanding. Special appreciation goes to the adolescent girls and young women of Majengo Slums, my research assistants and all those who agreed to take part in this study, they played a critical role in making the findings of this research a success.
  • Profil Toxicologique 4-Tert-Butylphénol (N°CAS 98-54-4)

    Profil Toxicologique 4-Tert-Butylphénol (N°CAS 98-54-4)

    Caractérisation des dangers et des expositions du 4-tert-butylphénol Avis de l’Anses Rapports d’expertise collective Décembre 2015 Édition scientifique Caractérisation des dangers et des expositions du 4-tert-butylphénol Avis de l’Anses Rapports d’expertise collective Décembre 2015 Édition scientifique Avis de l’Anses Saisine n° «2009-SA-0331» Le directeur général Maisons-Alfort, le 10 décembre 2015 AVIS de l’Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail relatif à la caractérisation des dangers et des expositions du 4-chloro-3-méthylphénol ou p-chlorocrésol (n° CAS 59-50-7), 4-nitrophénol (n° CAS 100-02- 7), 4-tert-octylphénol (n° CAS 140-66-9), DEGME (ou 2-(2-méthoxyéthoxy)ethanol) (n° CAS 11-77-3), 4-tert-butylphénol (n° CAS 98-54-4), 4-nonylphénol (n° CAS 104-40-5) L’Anses met en œuvre une expertise scientifique indépendante et pluraliste. L’Anses contribue principalement à assurer la sécurité sanitaire dans les domaines de l’environnement, du travail et de l’alimentation et à évaluer les risques sanitaires qu’ils peuvent comporter. Elle contribue également à assurer d’une part la protection de la santé et du bien-être des animaux et de la santé des végétaux et d’autre part l’évaluation des propriétés nutritionnelles des aliments. Elle fournit aux autorités compétentes toutes les informations sur ces risques ainsi que l’expertise et l’appui scientifique technique nécessaires à l’élaboration des dispositions législatives et réglementaires et à la mise en œuvre des mesures de gestion du risque (article L.1313-1 du code de la santé publique).